Works by Stewart, A. Keith


Results: 139
    1
    2
    3
    4

    In retrospect.

    Published in:
    1997
    By:
    • Thomson, Keith Stewart
    Publication type:
    Book Review
    5

    Fossil fish.

    Published in:
    1995
    By:
    • Thomson, Keith Stewart
    Publication type:
    Book Review
    6

    Buried treasures.

    Published in:
    1994
    By:
    • Thomson, Keith Stewart
    Publication type:
    Book Review
    7

    Nothing doing.

    Published in:
    1993
    By:
    • Thomson, Keith Stewart
    Publication type:
    Book Review
    8

    Meatoplasty transposition flaps.

    Published in:
    Laryngoscope, 1972, v. 82, n. 3, p. 404, doi. 10.1288/00005537-197203000-00007
    By:
    • Beal, David D.;
    • Stewart, Keith C.;
    • Stallings, James O.;
    • Sessions, Donald G.
    Publication type:
    Article
    9
    10
    11

    Mass Cytometry reveals unique phenotypic patterns associated with subclonal diversity and outcomes in multiple myeloma.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00851-5
    By:
    • Baughn, Linda B.;
    • Jessen, Erik;
    • Sharma, Neeraj;
    • Tang, Hongwei;
    • Smadbeck, James B.;
    • Long, Mark D.;
    • Pearce, Kathryn;
    • Smith, Matthew;
    • Dasari, Surendra;
    • Sachs, Zohar;
    • Linden, Michael A.;
    • Cook, Joselle;
    • Keith Stewart, A.;
    • Chesi, Marta;
    • Mitra, Amit;
    • Leif Bergsagel, P.;
    • Van Ness, Brian;
    • Kumar, Shaji K.
    Publication type:
    Article
    12

    Prognostic value of early bone marrow MRD status in CAR-T therapy for myeloma.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00820-y
    By:
    • Bansal, Radhika;
    • Baksh, Mizba;
    • Larsen, Jeremy T.;
    • Hathcock, Matthew A.;
    • Dingli, David;
    • Stewart, A. Keith;
    • Kapoor, Prashant;
    • Kourelis, Taxiarchis;
    • Hayman, Suzanne R.;
    • Warsame, Rahma M.;
    • Fonseca, Rafael;
    • Bergsagel, P. Leif;
    • Ailawadhi, Sikander;
    • Kumar, Shaji K.;
    • Lin, Yi
    Publication type:
    Article
    13

    Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00794-x
    By:
    • Fonseca, Rodrigo;
    • Arribas, Mariano;
    • Wiedmeier-Nutor, Julia E.;
    • Kusne, Yael N.;
    • González Vélez, Miguel;
    • Kosiorek, Heidi E.;
    • Butterfield, Richard J.;
    • Kirsch, Ilan R.;
    • Mikhael, Joseph R.;
    • Stewart, A. Keith;
    • Reeder, Craig;
    • Larsen, Jeremy;
    • Bergsagel, P. Leif;
    • Fonseca, Rafael
    Publication type:
    Article
    14

    Mass Cytometry reveals unique phenotypic patterns associated with subclonal diversity and outcomes in multiple myeloma.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00851-5
    By:
    • Baughn, Linda B.;
    • Jessen, Erik;
    • Sharma, Neeraj;
    • Tang, Hongwei;
    • Smadbeck, James B.;
    • Long, Mark D.;
    • Pearce, Kathryn;
    • Smith, Matthew;
    • Dasari, Surendra;
    • Sachs, Zohar;
    • Linden, Michael A.;
    • Cook, Joselle;
    • Keith Stewart, A.;
    • Chesi, Marta;
    • Mitra, Amit;
    • Leif Bergsagel, P.;
    • Van Ness, Brian;
    • Kumar, Shaji K.
    Publication type:
    Article
    15

    Prognostic value of early bone marrow MRD status in CAR-T therapy for myeloma.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00820-y
    By:
    • Bansal, Radhika;
    • Baksh, Mizba;
    • Larsen, Jeremy T.;
    • Hathcock, Matthew A.;
    • Dingli, David;
    • Stewart, A. Keith;
    • Kapoor, Prashant;
    • Kourelis, Taxiarchis;
    • Hayman, Suzanne R.;
    • Warsame, Rahma M.;
    • Fonseca, Rafael;
    • Bergsagel, P. Leif;
    • Ailawadhi, Sikander;
    • Kumar, Shaji K.;
    • Lin, Yi
    Publication type:
    Article
    16

    Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00794-x
    By:
    • Fonseca, Rodrigo;
    • Arribas, Mariano;
    • Wiedmeier-Nutor, Julia E.;
    • Kusne, Yael N.;
    • González Vélez, Miguel;
    • Kosiorek, Heidi E.;
    • Butterfield, Richard J.;
    • Kirsch, Ilan R.;
    • Mikhael, Joseph R.;
    • Stewart, A. Keith;
    • Reeder, Craig;
    • Larsen, Jeremy;
    • Bergsagel, P. Leif;
    • Fonseca, Rafael
    Publication type:
    Article
    17
    18
    19

    Mate pair sequencing outperforms fluorescence in situ hybridization in the genomic characterization of multiple myeloma.

    Published in:
    Blood Cancer Journal, 2019, v. 9, n. 12, p. 1, doi. 10.1038/s41408-019-0255-z
    By:
    • Smadbeck, James;
    • Peterson, Jess F.;
    • Pearce, Kathryn E.;
    • Pitel, Beth A.;
    • Figueroa, Andrea Lebron;
    • Timm, Michael;
    • Jevremovic, A. Dragan;
    • Shi, Min;
    • Stewart, A. Keith;
    • Braggio, Esteban;
    • Riggs, Daniel L.;
    • Bergsagel, P. Leif;
    • Vasmatzis, George;
    • Kearney, Hutton M.;
    • Hoppman, Nicole L.;
    • Ketterling, Rhett P.;
    • Kumar, Shaji;
    • Rajkumar, S. Vincent;
    • Greipp, Patricia T.;
    • Baughn, Linda B.
    Publication type:
    Article
    20

    Alu-dependent RNA editing of GLI1 promotes malignant regeneration in multiple myeloma.

    Published in:
    Nature Communications, 2017, v. 8, n. 1, p. 1, doi. 10.1038/s41467-017-01890-w
    By:
    • Lazzari, Elisa;
    • Mondala, Phoebe K.;
    • Santos, Nathaniel Delos;
    • Miller, Amber C.;
    • Pineda, Gabriel;
    • Jiang, Qingfei;
    • Heather Leu;
    • Ali, Shawn A.;
    • Ganesan, Anusha-Preethi;
    • Wu, Christina N.;
    • Costello, Caitlin;
    • Minden, Mark;
    • Chiaramonte, Raffaella;
    • Keith Stewart, A.;
    • Crews, Leslie A.;
    • Jamieson, Catriona H. M.
    Publication type:
    Article
    21
    22
    23
    24
    25

    Clinical correlates and prognostic impact of clonal hematopoiesis in multiple myeloma patients receiving post‐autologous stem cell transplantation lenalidomide maintenance therapy.

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 5, p. E157, doi. 10.1002/ajh.26125
    By:
    • Wudhikarn, Kitsada;
    • Padrnos, Leslie;
    • Lasho, Terra;
    • LaPlant, Betsy;
    • Kumar, Shaji;
    • Dispenzieri, Angela;
    • Lacy, Martha;
    • Rajkumar, S. Vincent;
    • Gertz, Morie;
    • Mangaonkar, Abhishek A.;
    • Gonsalves, Wilson;
    • Ketterling, Rhett;
    • Shi, Chang‐Xin;
    • Fonseca, Rafael;
    • Stewart, A. Keith;
    • Patnaik, Mrinal M.
    Publication type:
    Article
    26

    A phase 2 study of lenalidomide, rituximab, cyclophosphamide, and dexamethasone (LR-CD) for untreated low-grade non-Hodgkin lymphoma requiring therapy.

    Published in:
    American Journal of Hematology, 2017, v. 92, n. 5, p. 467, doi. 10.1002/ajh.24693
    By:
    • Rosenthal, Allison;
    • Dueck, Amylou C.;
    • Ansell, Stephen;
    • Gano, Katherine;
    • Conley, Christopher;
    • Nowakowski, Grzegorz S.;
    • Camoriano, John;
    • Leis, Jose F.;
    • Mikhael, Joseph R.;
    • Keith Stewart, A.;
    • Inwards, David;
    • Dingli, David;
    • Kumar, Shaji;
    • Noel, Pierre;
    • Gertz, Morie;
    • Porrata, Luis;
    • Russell, Stephen;
    • Colgan, Joseph;
    • Fonseca, Rafael;
    • Habermann, Thomas M.
    Publication type:
    Article
    27
    28

    Lenalidomide, cyclophosphamide and dexamethasone (CRd) for newly diagnosed multiple myeloma: Results from a phase 2 trial.

    Published in:
    American Journal of Hematology, 2011, v. 86, n. 8, p. 640, doi. 10.1002/ajh.22053
    By:
    • Kumar, Shaji K.;
    • Lacy, Martha Q.;
    • Hayman, Suzanne R.;
    • Stewart, Keith;
    • Buadi, Francis K.;
    • Allred, Jacob;
    • Laumann, Kristina;
    • Greipp, Philip R.;
    • Lust, John A.;
    • Gertz, Morie A.;
    • Zeldenrust, Steven R.;
    • Bergsagel, P. Leif;
    • Reeder, Craig B.;
    • Witzig, Thomas E.;
    • Fonseca, Rafael;
    • Russell, Stephen J.;
    • Mikhael, Joseph R.;
    • Dingli, David;
    • Rajkumar, S. Vincent;
    • Dispenzieri, Angela
    Publication type:
    Article
    29

    Clarithromycin (Biaxin)-lenalidomide-low-dose dexamethasone (BiRd) versus lenalidomide-low-dose dexamethasone (Rd) for newly diagnosed myeloma.

    Published in:
    American Journal of Hematology, 2010, v. 85, n. 9, p. 664, doi. 10.1002/ajh.21777
    By:
    • Gay, Francesca;
    • Rajkumar, S. Vincent;
    • Coleman, Morton;
    • Kumar, Shaji;
    • Mark, Tomer;
    • Dispenzieri, Angela;
    • Pearse, Roger;
    • Gertz, Morie A.;
    • Leonard, John;
    • Lacy, Martha Q.;
    • Chen-Kiang, Selina;
    • Roy, Vivek;
    • Jayabalan, David S.;
    • Lust, John A.;
    • Witzig, Thomas E.;
    • Fonseca, Rafael;
    • Kyle, Robert A.;
    • Greipp, Philip R.;
    • Stewart, A. Keith;
    • Niesvizky, Ruben
    Publication type:
    Article
    30
    31
    32

    Improvements in Renal Function with Selinexor in Relapsed/Refractory Multiple Myeloma: Post-hoc Analyses from the STORM Study.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e118, doi. 10.1016/j.clml.2019.09.196
    By:
    • Vogl, Dan T.;
    • Nooka, Ajay;
    • Gavriatopoulou, Maria;
    • Yee, Andrew;
    • Huff, Carol;
    • Moreau, Philippe;
    • Dingli, David;
    • Cole, Craig;
    • Richardson, Paul G.;
    • Dimopoulos, Meletios A.;
    • Lonial, Sagar;
    • Stewart, Keith;
    • Chari, Ajai;
    • Richter, Joshua;
    • Biran, Noa;
    • Siegel, David S.;
    • Liu, Jianjun;
    • Joshi, Anita;
    • Shah, Jatin;
    • Shacham, Sharon
    Publication type:
    Article
    33

    Effect of Age on the Safety and Efficacy of Selinexor in Patients with Relapsed Refractory Multiple Myeloma: A Post-hoc Analysis of the STORM Study.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e117, doi. 10.1016/j.clml.2019.09.195
    By:
    • Gavriatopoulou, Maria;
    • Vogl, Dan T.;
    • Nooka, Ajay;
    • Dingli, David;
    • Cole, Craig;
    • Moreau, Philippe;
    • Huff, Carol;
    • Yee, Andrew;
    • Dimopoulos, Meletios A.;
    • Lonial, Sagar;
    • Richardson, Paul G.;
    • Stewart, Keith;
    • Chari, Ajai;
    • Richter, Joshua;
    • Biran, Noa;
    • Siegel, David S.;
    • Liu, Jianjun;
    • Joshi, Anita;
    • Shah, Jatin;
    • Shacham, Sharon
    Publication type:
    Article
    34

    Ex vivo sensitivity to venetoclax is predictive of clinical activity.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e114, doi. 10.1016/j.clml.2019.09.189
    By:
    • Bonolo de Campos, Cecilia;
    • Meurice, Nathalie;
    • Bruins, Laura A.;
    • Petit, Joachim L.;
    • Polito, Alysia N.;
    • Wang, Xuewei;
    • Zhu, Yuan Xiao;
    • Shi, Chang-Xin;
    • Ahmann, Greg J.;
    • Braggio, Esteban;
    • Stewart, Keith
    Publication type:
    Article
    35
    36

    Mate pair sequencing outperforms fluorescence in situ hybridization and improves diagnostic yield in the genomic characterization of multiple myeloma.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e58, doi. 10.1016/j.clml.2019.09.090
    By:
    • Baughn, Linda;
    • James, Smadbeck;
    • Kathryn, Pearce;
    • Pitel, Beth;
    • Timm, Michael;
    • Bergsagel, Leif;
    • Jevremovic, Dragan;
    • Shi, Min;
    • Stewart, Keith;
    • Braggio, Esteban;
    • Riggs, Daniel;
    • George, Vasmatzis;
    • Kearney, Hutton;
    • Hoppman, Nicole;
    • Ketterling, Rhett;
    • Greipp, Patricia;
    • Kumar, Shaji;
    • Rajkumar, S.Vincent;
    • Peterson, Jess
    Publication type:
    Article
    37
    38

    Phase 2b Results of the STORM Study: Oral Selinexor plus Low Dose Dexamethasone (Sd) in Patients with Penta-Refractory Myeloma (penta-MM).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S249, doi. 10.1016/j.clml.2018.07.149
    By:
    • Jagannath, Sundar;
    • Vogl, Dan T.;
    • Dimopoulos, Meletios-Athanasios;
    • Nooka, Ajay;
    • Huff, Carol;
    • Moreau, Philippe;
    • Cole, Craig;
    • Richter, Josh;
    • Dingli, David;
    • Vij, Ravi;
    • Tuchman, Sascha;
    • Raab, Marc-Steffen;
    • Weisel, Katja;
    • Delforge, Michel;
    • Kaminetzky, David;
    • Cornell, Robert Frank;
    • Stewart, A. Keith;
    • Hoffman, James;
    • Godby, Kelly N.;
    • Parker, Terri Lynn
    Publication type:
    Article
    39
    40

    Deep and Durable Responses with Weekly Ixazomib, Lenalidomide, and Dexamethasone in Patients with Newly Diagnosed Multiple Myeloma (NDMM): Long-Term Follow-up of Patients Not Undergoing Stem Cell Transplantation (SCT).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S335, doi. 10.1016/j.clml.2017.07.151
    By:
    • Kumar, Shaji;
    • Berdeja, Jesus;
    • Niesvizky, Ruben;
    • Lonial, Sagar;
    • Laubach, Jacob;
    • Hamadani, Mehdi;
    • Stewart, A. Keith;
    • Hari, Parameswaran;
    • Roy, Vivek;
    • Vescio, Robert;
    • Kaufman, Jonathan;
    • Berg, Deborah;
    • Liao, Eileen;
    • Rajkumar, Vincent;
    • Richardson, Paul
    Publication type:
    Article
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50